To include your compound in the COVID-19 Resource Center, submit it here.

Iniparib: Additional Phase III data

Additional data from an open-label, U.S. Phase III trial in 519 women with metastatic triple-negative breast cancer showed that IV BSI-201 plus gemcitabine and

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE